Mostrar el registro sencillo del ítem
dc.contributor.author | Martorell-Tejedor, Sara | es_ES |
dc.contributor.author | Hueso, Luisa | es_ES |
dc.contributor.author | Gonzalez-Navarro, Herminia | es_ES |
dc.contributor.author | Collado, Aida | es_ES |
dc.contributor.author | Sanz, María-Jesús | es_ES |
dc.contributor.author | Piqueras, Laura | es_ES |
dc.date.accessioned | 2024-02-12T11:16:24Z | |
dc.date.available | 2024-02-12T11:16:24Z | |
dc.date.issued | 2016-08 | es_ES |
dc.identifier.issn | 1079-5642 | es_ES |
dc.identifier.uri | http://hdl.handle.net/10251/202586 | |
dc.description.abstract | [EN] Objective Abdominal aortic aneurysm (AAA) is a vascular disorder characterized by chronic inflammation of the aortic wall. Low concentrations of vitamin D-3 are associated with AAA development; however, the potential direct effect of vitamin D-3 on AAA remains unknown. This study evaluates the effect of oral treatment with the vitamin D-3 receptor (VDR) ligand, calcitriol, on dissecting AAA induced by angiotensin-II (Ang-II) infusion in apoE(-/-) mice. Approach and Results Oral treatment with calcitriol reduced Ang-II-induced dissecting AAA formation in apoE(-/-) mice, which was unrelated to systolic blood pressure or plasma cholesterol concentrations. Immunohistochemistry and reverse-transcription polymerase chain reaction analysis demonstrated a significant increase in macrophage infiltration, neovessel formation, matrix metalloproteinase-2 and matrix metalloproteinase-9, chemokine (CCL2 [(C-C motif) ligand 2], CCL5 [(C-C motif) ligand 5], and CXCL1 [(C-X-C motif) ligand 1]) and vascular endothelial growth factor expression in suprarenal aortic walls of apoE(-/-) mice infused with Ang-II, and all were significantly reduced by cotreatment with calcitriol. Phosphorylation of extracellular signal-regulated kinases 1/2, p38 mitogen-activated protein kinase, and nuclear factor-B was also decreased in the suprarenal aortas of apoE(-/-) mice cotreated with calcitriol. These effects were accompanied by a marked increase in VDR-retinoid X receptor (RXR) interaction in the aortas of calcitriol-treated mice. In vitro, VDR activation by calcitriol in human endothelial cells inhibited Ang-II-induced leukocyte-endothelial cell interactions, morphogenesis, and production of endothelial proinflammatory and angiogenic chemokines through VDR-RXR interactions, and knockdown of VDR or RXR abolished the inhibitory effects of calcitriol. Conclusions VDR activation reduces dissecting AAA formation induced by Ang-II in apoE(-/-) mice and may constitute a novel therapeutic strategy to prevent AAA progression. | es_ES |
dc.description.sponsorship | This study was supported by grants CPII13/00025, PI12/01271, PI15/00082, PIE15/00013, SAF2011-23777, and SAF2014-57845-R from the Carlos III Health Institute, the Spanish Ministry of Health, the Spanish Ministry of Economy and Competiveness, and the European Regional Development Fund (FEDER), an Intramural grant from INCLIVA, and research grants from the Generalitat Valenciana (GVACOMP2014-006 and PROMETEO II/2013/014). | es_ES |
dc.language | Inglés | es_ES |
dc.publisher | Ovid Technologies Wolters Kluwer -American Heart Association | es_ES |
dc.relation.ispartof | Arteriosclerosis Thrombosis and Vascular Biology | es_ES |
dc.rights | Reserva de todos los derechos | es_ES |
dc.subject | Abdominal aortic aneurysm | es_ES |
dc.subject | Calcitriol | es_ES |
dc.subject | Chemokines | es_ES |
dc.subject | Endothelial cells inflammation | es_ES |
dc.subject | Dilatation | es_ES |
dc.title | Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice | es_ES |
dc.type | Artículo | es_ES |
dc.identifier.doi | 10.1161/ATVBAHA.116.307530 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/MICINN//SAF2011-23777/ES/ESTUDIO DE LOS MECANISMOS MOLECULARES Y CELULARES EN LA DISFUNCION ENDOTELIAL ASOCIADA A ENFERMEDADES CON INFLAMACION SISTEMICA QUE PODRIAN INDUCIR DESORDENES CARDIOVASCULARES/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//CD13%2F00025/ES/CD13%2F00025/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//PI12%2F01271/ES/ESTUDIO DE NUEVOS MARCADORES INFLAMATORIOS EN LA DISFUNCION ENDOTELIAL: PAPEL MODULADOR DE LIGANDOS DE PPAR Y RXR/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//PI15%2F00082/ES/Estudio de nuevos mecanismos inflamatorios y angiogénicos asociados a la obesidad grave mórbida: Papel del eje CXCR3 y los receptores nucleares RORs/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//PIE15%2F00013/ES/A multidisciplinary project to advance in basic mechanisms, diagnosis, prediction, and prevention of cardiac damage in reperfused acute myocardial infarction/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//SAF2014-57845-R/ES/MODULACION INMUNOFARMACOLOGICA DE LA INFLAMACION SISTEMICA ASOCIADA A DESORDENES METABOLICOS. BUSQUEDA DE NUEVAS DIANAS TERAPEUTICAS Y SINTESIS DE FARMACOS NOVEDOSOS/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/GVA//PROMETEO%2F2013%2F014//SINTESIS DE GRAFENO Y DERIVADOS COMO SENSORES O CON PROPIEDADES OPTOELECTRONICAS/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/GVA//GVACOMP2014-006/ | es_ES |
dc.rights.accessRights | Cerrado | es_ES |
dc.description.bibliographicCitation | Martorell-Tejedor, S.; Hueso, L.; Gonzalez-Navarro, H.; Collado, A.; Sanz, M.; Piqueras, L. (2016). Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice. Arteriosclerosis Thrombosis and Vascular Biology. 36(8):1587-1597. https://doi.org/10.1161/ATVBAHA.116.307530 | es_ES |
dc.description.accrualMethod | S | es_ES |
dc.relation.publisherversion | https://doi.org/10.1161/ATVBAHA.116.307530 | es_ES |
dc.description.upvformatpinicio | 1587 | es_ES |
dc.description.upvformatpfin | 1597 | es_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | es_ES |
dc.description.volume | 36 | es_ES |
dc.description.issue | 8 | es_ES |
dc.identifier.pmid | 27283745 | es_ES |
dc.relation.pasarela | S\327999 | es_ES |
dc.contributor.funder | Generalitat Valenciana | es_ES |
dc.contributor.funder | European Regional Development Fund | es_ES |
dc.contributor.funder | Ministerio de Ciencia e Innovación | es_ES |
dc.contributor.funder | Ministerio de Economía y Competitividad | es_ES |
dc.contributor.funder | Instituto de Investigación Sanitaria INCLIVA | es_ES |